Laura Amanda Vallejo-Aparicio

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Randomized Controlled Trial

Community Dwelling

Top Venues

Human vaccines & immunotherapeutics

PharmacoEconomics - open

International journal of chronic obstructive pulmonary disease

Infectious diseases and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Alberto Pérez, María Fernández Prada, Natalia Cassinello, Laura Amanda Vallejo-Aparicio, Andrea García, Almudena González, Ana Durán, Néboa Zozaya, Irene Fernández, Mathilde Daheron, Álvaro Hidalgo, Ekkehard Beck, Antonio García Ruiz
Cost-benefit analysis of the National Immunization Program in Spain. Human vaccines & immunotherapeutics 20 (1) (2024)
Alberto Pérez, María Fernández Prada, Natalia Cassinello, Laura Amanda Vallejo-Aparicio, Andrea García, Almudena González, Ana Durán, Néboa Zozaya, Irene Fernández, Mathilde Daheron, Álvaro Hidalgo, Ekkehard Beck, Antonio García Ruiz
Cost-benefit analysis of the National Immunization Program in Spain. Human vaccines & immunotherapeutics 20 (1) (2024)
Andrea García, Laura Amanda Vallejo-Aparicio, Maria Del Rosario Cambronero
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain. Human vaccines & immunotherapeutics 20 (1) (2024)
Andrea García, Laura Amanda Vallejo-Aparicio, Maria Del Rosario Cambronero
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain. Human vaccines & immunotherapeutics 20 (1) (2024)
Alberto Pérez, María Fernández Prada, Natalia Cassinello, Laura Amanda Vallejo-Aparicio, Andrea García, Almudena González, Ana Durán, Néboa Zozaya, Irene Fernández, Mathilde Daheron, Álvaro Hidalgo, Ekkehard Beck, Antonio García Ruiz
Cost-benefit analysis of the National Immunization Program in Spain. Human vaccines & immunotherapeutics 20 (1) (2024)
Andrea García, Laura Amanda Vallejo-Aparicio, Maria Del Rosario Cambronero
The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain. Human vaccines & immunotherapeutics 20 (1) (2024)
Santiago Moreno, Antonio Rivero, Pere Ventayol, Vicenç Falcó, Miguel Torralba González de Suso, Melanie Schroeder, Victoria Neches, Laura Amanda Vallejo-Aparicio, Isaac Mackenzie, Matthew Turner, Cale Harrison
Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain. Infectious diseases and therapy (2023)
Ángel Gil de Miguel, José María Eiros Bouza, Luis Ignacio Martínez Alcorta, Daniel Callejo Velasco, Carlos Miñarro, Laura Amanda Vallejo-Aparicio, Andrea García, Mónica Tafalla, Maria Del Rosario Cambronero, Rubén Rodríguez, Laura Martin-Gomez
Direct Medical Costs of Four Vaccine-Preventable Infectious Diseases in Older Adults in Spain. PharmacoEconomics - open 6 (4) (2022)
Victoria Neches, Laura Amanda Vallejo-Aparicio, Afisi S Ismaila, Antoni Sicras Mainar, Aram Sicras-Navarro, Cruz González, Rafael Cuervo, Soham Shukla, Marcos García-Peñuela
Clinical and Economic Impact of Long-Term Inhaled Corticosteroid Withdrawal in Patients with Chronic Obstructive Pulmonary Disease Treated with Triple Therapy in Spain. International journal of chronic obstructive pulmonary disease 17 (2022)